Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells.
Korpetinou A, Skandalis SS, Moustakas A, Happonen KE, Tveit H, Prydz K, Labropoulou VT, Giannopoulou E, Kalofonos HP, Blom AM, Karamanos NK, Theocharis AD.
Korpetinou A, et al. Among authors: happonen ke.
PLoS One. 2013 Oct 31;8(10):e78157. doi: 10.1371/journal.pone.0078157. eCollection 2013.
PLoS One. 2013.
PMID: 24205138
Free PMC article.